Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for iSpecimen Inc. (ISPC : NSDQ)

• Company Description    iSpecimen Inc. offers an online marketplace for human biospecimens, connecting life scientists in commercial and non-profit organizations with healthcare providers which have access to patients and specimens needed for medical discovery. iSpecimen Inc. is based in LEXINGTON, Mass. Number of Employees: 24

• Price / Volume Information    Yesterday's Closing Price: $1.05 Daily Weekly Monthly 20 Day Moving Average: 53,046 shares Shares Outstanding: 2.50 (millions) Market Capitalization: $2.62 (millions) Beta: 1.61 52 Week High: $8.30 52 Week Low: $0.86 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -0.94% -5.42% 12 Week -14.98% -28.25% Year To Date -60.45% -62.84%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 8 CABOT ROAD - WOBURN,MA 01801 USA ph: 781-301-6700 fax: - ispecimen@kcsa.com http://www.ispecimen.com

• General Corporate Information    Officers Robert Bradley Lim - Chief Executive Officer; Treasurer; Secretary and Richard Paolone - Chairman of the Board Katharyn (Katie) Field - President Yuying Liang - Chief Financial Officer Siyun Yang - Director Peer Information iSpecimen Inc. (CHCR) iSpecimen Inc. (ESRX) iSpecimen Inc. (MYDP) iSpecimen Inc. (COR) iSpecimen Inc. (GBCS) iSpecimen Inc. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 45032V207 SIC: 8731 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/05/25 Share - Related Items Shares Outstanding: 2.50 Most Recent Split Date: 9.00 (0.05:1) Beta: 1.61 Market Capitalization: $2.62 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/05/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.57 Price/Cash Flow: - Price / Sales: 0.33 EPS Growth vs. Year Ago Period: 88.91% vs. Previous Quarter: 88.69% Sales Growth vs. Year Ago Period: -53.80% vs. Previous Quarter: -28.32% ROE 06/30/25 - - 03/31/25 - -285.20 12/31/24 - -238.88 ROA 06/30/25 - - 03/31/25 - -114.37 12/31/24 - -111.02 Current Ratio 06/30/25 - - 03/31/25 - 0.31 12/31/24 - 0.62 Quick Ratio 06/30/25 - - 03/31/25 - 0.31 12/31/24 - 0.62 Operating Margin 06/30/25 - - 03/31/25 - -139.63 12/31/24 - -134.50 Net Margin 06/30/25 - - 03/31/25 - -139.63 12/31/24 - -134.50 Pre-Tax Margin 06/30/25 - - 03/31/25 - -139.63 12/31/24 - -134.52 Book Value 06/30/25 - - 03/31/25 - 0.67 12/31/24 - 1.95 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00 Debt-to-Capital 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00

Powered by Zacks Investment Research ©